The TCF21 gene has been associated with CAD, promoting the stability of plaques and reducing clinical events by modulating the phenotypic transition from smooth muscle cells to fibromyocytes in atherosclerosis 44. The gene discussed is TCF21; the disease is coronary artery disorder.